Share Price
For Investor Relations inquiries, please contact PureTech's Investor Relations team at: ir@puretechhealth.com.
1This represents a non-IFRS number and is comprised of cash, cash equivalents and short-term investments held at PureTech Health plc and our wholly-owned subsidiaries (PureTech LYT, PureTech LYT-100, Alivio Therapeutics, Inc., PureTech Management, Inc., PureTech Health LLC, PureTech Securities Corp, PureTech Securities II) as of March 31, 2023. Please see below for a reconciliation of this measure to consolidated cash, cash equivalents and short-term investments, which is the most directly comparable measure calculated in accordance with IFRS
